ImmunityBio, Inc. — Director's Dealing 2020

Mar 24, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2020-03-23

Reporting Person: Nelson Sonja (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-23	Common Stock	M	15000	$0.00	Acquired	36542	Direct
2020-03-23	Common Stock	F	6132	$2.82	Disposed	30410	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-23	Restricted Stock Units	$	M	15000	Disposed		Common Stock (15000)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of NantKwest, Inc. common stock.

F2: Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through each applicable vesting date, the restricted stock units ("RSUs") will vest as follows: 50% of the RSUs vested on March 23, 2018, and the remaining 50% of the RSUs vested on March 23, 2020.